Purple Biotech Ltd
NASDAQ:PPBT
Income Statement
Earnings Waterfall
Purple Biotech Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-22.3m
USD
|
Operating Income
|
-22.3m
USD
|
Other Expenses
|
2.4m
USD
|
Net Income
|
-19.9m
USD
|
Income Statement
Purple Biotech Ltd
Dec-2019 | Jun-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||
Revenue |
1
N/A
|
1
N/A
|
0
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||
Operating Expenses |
(8)
|
(9)
|
(13)
|
(25)
|
(23)
|
(26)
|
(18)
|
(18)
|
(18)
|
(20)
|
(23)
|
(20)
|
(22)
|
(23)
|
(22)
|
|
Selling, General & Administrative |
(5)
|
(5)
|
(6)
|
(10)
|
(9)
|
(11)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(6)
|
(6)
|
(5)
|
|
Research & Development |
(3)
|
(4)
|
(7)
|
(8)
|
(7)
|
(9)
|
(12)
|
(13)
|
(13)
|
(14)
|
(16)
|
(14)
|
(15)
|
(17)
|
(17)
|
|
Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(7)
N/A
|
(8)
-16%
|
(13)
-62%
|
(24)
-82%
|
(23)
+3%
|
(26)
-13%
|
(18)
+32%
|
(18)
-3%
|
(18)
+0%
|
(20)
-11%
|
(23)
-11%
|
(20)
+10%
|
(22)
-8%
|
(23)
-3%
|
(22)
+1%
|
|
Pre-Tax Income | ||||||||||||||||
Interest Income Expense |
1
|
(23)
|
(15)
|
(39)
|
(15)
|
(15)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(6)
N/A
|
(31)
-444%
|
(29)
+7%
|
(63)
-119%
|
(39)
+38%
|
(42)
-8%
|
(18)
+57%
|
(18)
-3%
|
(18)
+1%
|
(20)
-10%
|
(22)
-8%
|
(19)
+11%
|
(21)
-8%
|
(21)
-1%
|
(20)
+6%
|
|
Net Income | ||||||||||||||||
Tax Provision |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(6)
|
(31)
|
(29)
|
(63)
|
(39)
|
(42)
|
(18)
|
(18)
|
(18)
|
(20)
|
(22)
|
(19)
|
(21)
|
(21)
|
(20)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(6)
N/A
|
(31)
-431%
|
(28)
+10%
|
(62)
-123%
|
(38)
+39%
|
(41)
-8%
|
(18)
+55%
|
(19)
-4%
|
(19)
+0%
|
(21)
-9%
|
(22)
-5%
|
(19)
+11%
|
(21)
-8%
|
(21)
-1%
|
(20)
+6%
|
|
EPS (Diluted) |
-0.3
N/A
|
-0.51
-70%
|
-0.25
+51%
|
-3.58
-1 332%
|
-2.17
+39%
|
-2.34
-8%
|
-0.1
+96%
|
-1.07
-970%
|
-0.1
+91%
|
-0.11
-10%
|
-1.2
-991%
|
-0.1
+92%
|
-0.11
-10%
|
-0.1
+9%
|
-0.05
+50%
|